1Chen C, Matesic LE. The Nedd4-like family of E3 ubiquitin ligases and cancer ~J]. Cancer Metastasis Rev., 2007, 26(3-4):587-604.
2Adhikary S, Marinoni F, Hock A, et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation [J]. Cell, 2005, 123(3):409-421.
3Rayburn E, Zhang R, He J, et al. MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy[J]. Curr Cancer Drug Targets,2005,5(1) :27-41.
4Sun Y. E3 ubiquitin ligases as cancer targets and biomarkers[J]. Neoplasia, 2006, 8(8):645-54.
5Nakayama KI, Nakayama K. Ubiquitin ligases:cellcycle control and cancer[J]. Nat Rev Cancer, 2006,6 (5):369-381.
6Kim SY, Herbst A, Tworkowski KA, et al. Skp2 regulates Myc protein stability and activity[J]. Mol Cell,2003,11 (5) : 1177-1188.
7Von der Lehr N, Johansson S, Wu S, et al. The F- box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc - regulatedtranscription[J]. Mol Cell, 2003,11(5):1189- 1200.
8Wang Q, Moyret-Lalle C, Couzon F, et al. Alterations of anaphase-promoting complex genes in human colon cancer cells[J]. Oncogene, 2003,22 (10): 1486- 1490.
9Chen D, Kon N, Li M, et al. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor[J]. Cell, 2005,121 (7) : 1071-1083.
10Billack B, Monteiro AN. BRCA1 in breast and ovarian cancer predisposition[J]. Cancer lett,2005,227(1) : 1- 7.
